Bijoy Hans Ltd (BSE: 524723) is a Guwahati, Assam-based company in the Pharmaceutical Product Distribution industry. With a market capitalisation of ₹523 Cr, it ranks #1,981 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 13 in Pharmaceutical Product Distribution. At ₹109.00 (as of 16 Nov 2026), the share price is 24.8% below its 52-week high of ₹145.00 and 128.4% above its 52-week low of ₹47.72. The share price is up 128.4% over one year and down 1.1% over three months.
| Current Price | ₹109.00 |
|---|---|
| Market Cap | ₹523 Cr |
| BSE Code | 524723 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Pharmaceutical Product Distribution |
| 52-Week Range | ₹47.72 – ₹145.00 |
| 1-Year Price Change | +128.4% |
| 3-Month Price Change | -1.1% |
| Beta (1Y) | -0.45 |
| Headquarters | Guwahati, Assam |
| Website | www.arvayahealth.com |
Delivery averaged 100.0% of traded volume across 14 BSE sessions (21 Oct 2026 – 11 Nov 2026).
Arvaya Healthcare Limited develops and provides a platform that combines hospitals, diagnostics, digital health technology, and wellness services. The company’s platform offers an artificial intelligence (AI) health assistant, providing personalized health guidance and proactive recommendations; seamless booking options, such as instant appointments, teleconsultations, and home diagnostic services; real-time tracking, including monitoring vitals, syncing wearables, and tracking health trends; and connected care that enables users to connect with doctors, labs, and pharmacies. Arvaya Healthcare Limited was formerly known as Bijoy Hans Limited and changed its name to Arvaya Healthcare Limited in May 2026. The company was incorporated in 1985 and is based in Miraj, India.
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | ₹8,733 Cr | 74.6 | 8.28% | ₹2,087 Cr | +80.7% |
| Remus Pharmaceuticals Limited | ₹941 Cr | 26.1 | 13.78% | — | +0.6% |
| Health X Platform Limited (Sastasundar Ventures Ltd) | ₹871 Cr | 752.7 | -0.18% | ₹484 Cr | -5.7% |
| Aptus Pharma Limited | ₹837 Cr | 156.8 | — | — | +754.0% |
| Vasa Denticity Limited | ₹797 Cr | 76.5 | 6.68% | ₹87 Cr | -21.4% |
| Bijoy Hans Ltd | ₹523 Cr | — | — | — | +128.4% |
| Speciality Medicines Limited | ₹149 Cr | 11.5 | — | — | — |
| Vijaypd Ceutical Limited | ₹136 Cr | 23 | 9.53% | — | — |
| Royal Sense Limited | ₹39 Cr | 5.6 | — | — | -71.2% |
Listed by market capitalisation. Ratios are shown for context only.
Bijoy Hans Ltd is trading at ₹109.00, with a market capitalisation of ₹523 Cr.
Bijoy Hans Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Pharmaceutical Product Distribution).
Bijoy Hans Ltd is listed on the BSE under the scrip code 524723.
Bijoy Hans Ltd's share price is up 128.4% over one year and down 1.1% over three months. Its 52-week range is ₹47.72 to ₹145.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.